Cancer incidence in persons with elevated cobalamin levels

European Journal of Clinical Investigation

Volumn 43, Issue 6, 2013, Pages 557-561

  Ryg, Jesper ^a,b   Nybo, Mads ^a,b   Hallas, Jesper ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cancer; Cohort study; Elevated cobalamin; Incidence

Indexed keywords

COBALAMIN;

ADULT; AGE; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCRIPTION; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

ADULT; AGED; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; VITAMIN B 12;

EID: 84877708661     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12076     Document Type: Article

References (27)

1. Carmel R, Vasireddy H, Aurangzeb I, George K. High serum cobalamin levels in the clinical setting-clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001;23:365-71.
2. Hom BL, Olesen H, Schwartz M. Turnover of 57Co-labelled vitamin B12-transcobalamin II and autologous 131-I-labelled IgG in a patient with antibody to transcobalamin II. Scand J Haematol 1968;5:107-15.
3. Schwartz M, Bastrup-Madsen P. A new vitamin B12 binding protein in serum causing excessively high serum vitamin B12 values. Scand J Haematol 1968;5:35-40.
4. Jeffery J, Millar H, Mackenzie P, Fahie-Wilson M, Hamilton M, Ayling RM. An IgG complexed form of vitamin B12 is a common cause of elevated serum concentrations. Clin Biochem 2010;43:82-8.
5. Ghosh K, Mohanty D, Rana KS, Hassan SW, Garewal G, Das KC. Plasma transcobalamins in haematological disorders. Folia Haematol Int Mag Klin Morphol Blutforsch 1986;113:766-75.
6. Dahlin AM, Van GB, Hultdin J, Johansson I, Hallmans G, Palmqvist R. Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study. Int J Cancer 2008;122:2057-61.
7. Gimsing P, Hippe E. Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast. Scand J Haematol 1978;21:243-9.
8. Carmel R. Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med 1975;292:282-4.
9. Carmel R, Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 1977;40:1348-53.
10. Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:1632-42.
11. Johansson M, Van GB, Vollset SE, Hultdin J, Bergh A, Key T et al. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev 2009;18:1538-43.
12. Johansson M, Relton C, Ueland PM, Vollset SE, Midttun O, Nygard O et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010;303:2377-85.
13. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 2002;6:39-42.
14. WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no/atc_ddd_index/. Accessed on 14 March 2013.
15. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
16. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:492-9.
17. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010;49:725-36.
18. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990;131:373-5.
19. Trousseau A. Phlegmasia alba dolens. In: Trousseau A, editor. Lectures on Clinical Medicine, Delivered at the Hotel-Dieu, Paris. Cormack JR, trans. London: New Sydenham Society; 1872: pp 281-95.
20. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998;351:1077-80.
21. Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994;308:891-4.
22. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998;338:1169-73.
23. Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med 2005;165:1167-72.
24. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-8.
25. Lildballe DL, Nguyen KQ, Poulsen SS, Nielsen HO, Nexo E. Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. Eur J Surg Oncol 2011;37:72-9.
26. Donkena KV, Yuan H, Young CY. Vitamin Bs, one carbon metabolism and prostate cancer. Mini Rev Med Chem 2010;10:1385-92.
27. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 4.0. Association of the Nordic Cancer Registries. Danish Cancer Society. Available at: http://www.ancr.nu. Accessed on 14 March 2013.